DekaBank Deutsche Girozentrale - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 152 filers reported holding PDL BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2020$133,000
-18.9%
50,1000.0%0.00%
-100.0%
Q3 2020$164,000
+43.9%
50,100
-3.5%
0.00%0.0%
Q3 2019$114,000
-64.0%
51,900
-50.0%
0.00%
-50.0%
Q2 2019$317,000
-17.9%
103,800
-35.8%
0.00%0.0%
Q1 2019$386,000
+173.8%
161,610
+211.4%
0.00%
+100.0%
Q4 2018$141,000
-63.5%
51,900
-67.9%
0.00%
-50.0%
Q3 2018$386,000
+2.9%
161,6100.0%0.00%0.0%
Q2 2018$375,000
-34.3%
161,610
-16.5%
0.00%
-50.0%
Q1 2018$571,000
+4.0%
193,610
-1.0%
0.00%0.0%
Q4 2017$549,0000.0%195,6100.0%0.00%0.0%
Q3 2017$549,000
+10.2%
195,6100.0%0.00%0.0%
Q2 2017$498,000
+137.1%
195,610
+100.8%
0.00%
+100.0%
Q1 2017$210,000
-7.5%
97,400
-7.6%
0.00%0.0%
Q4 2016$227,000
-27.9%
105,400
+8.2%
0.00%
-33.3%
Q3 2016$315,000
+3.6%
97,4000.0%0.00%0.0%
Q2 2016$304,000
+40.1%
97,400
+42.4%
0.00%0.0%
Q1 2016$217,000
-27.2%
68,400
-18.0%
0.00%0.0%
Q4 2015$298,000
-28.0%
83,400
+1.2%
0.00%
-40.0%
Q3 2015$414,000
-19.0%
82,400
+3.8%
0.01%
-16.7%
Q2 2015$511,000
-4.8%
79,400
+3.9%
0.01%
-14.3%
Q1 2015$537,000
-18.9%
76,400
-11.1%
0.01%
-12.5%
Q4 2014$662,000
-5.6%
85,900
-8.5%
0.01%
-11.1%
Q3 2014$701,000
-21.2%
93,900
+2.2%
0.01%
-30.8%
Q2 2014$890,000
+24.0%
91,900
+6.4%
0.01%
+18.2%
Q1 2014$718,000
+6.1%
86,400
+8.1%
0.01%0.0%
Q4 2013$677,000
+8.3%
79,900
+1.9%
0.01%0.0%
Q3 2013$625,00078,4000.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2019
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders